THE European Commission has
approved expanded options for
pre-treatment prior to use of
Qutenza (8% capsaicin patch), the
first and only licensed high
concentration capsaicin cutaneous
patch for the treatment of peripheral
neuropathic pain in Europe.
The expansion means that before
application a patient may now take
an oral analgesic, or the treatment
area may be pre-treated with a
topical anaesthetic.The above article was sent to subscribers in Pharmacy Daily's issue from 15 Mar 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 15 Mar 13
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.